KYTX — Kyverna Therapeutics, Inc. Common Stock · $488.8M cap

Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.

Use this KYTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KYTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KYTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Kyverna Therapeutics, Inc. Common Stock even when a live quote feed is slow.

Kyverna Therapeutics, Inc. Common Stock latest statements (FY2025)

Latest cached year on this hub. Full KYTX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$161.3M
  • Total Assets$293.8M
  • Total Debt$0
  • Free Cash Flow-$153.7M

KYTX recent filings